European Biotech Acquisit... (EBACU)
NASDAQ: EBACU
· Real-Time Price · USD
11.30
0.40 (3.67%)
At close: Mar 02, 2023, 9:53 PM
Company Description
European Biotech Acquisition Corp. does not have significant operations.
The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.
European Biotech Acquisition Corp.
| Country | NL |
| IPO Date | Mar 16, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Eduardo Bravo Fernandez de Araoz |
Contact Details
Address: Johannes Vermeerplein 9 Amsterdam, NL | |
| Website | https://www.lspvc.com/ebac |
Stock Details
| Ticker Symbol | EBACU |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001841258 |
| CUSIP Number | G3167F110 |
| ISIN Number | KYG3167F1101 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Eduardo Bravo Fernandez de Araoz | Chief Executive Officer & Director |
| Koen Sintnicolaas | Chief Financial Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 13, 2023 | 15-12G | Filing |
| Mar 02, 2023 | 25-NSE/A | [Amend] Filing |
| Feb 28, 2023 | 8-K | Current Report |
| Feb 28, 2023 | 10-K | Annual Report |
| Feb 21, 2023 | 8-K | Current Report |
| Feb 14, 2023 | DEFA14A | Filing |
| Feb 14, 2023 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Feb 14, 2023 | 8-K | Current Report |
| Feb 13, 2023 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Feb 06, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |